Immunohistochemical Localization of the IAP Protein Survivin in Bladder Mucosa and Transitional Cell Carcinoma
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 10 (2), 134-138
- https://doi.org/10.1097/00129039-200206000-00007
Abstract
In the current study, the immunohistochemical localization of survivin was correlated with the histologic diagnosis in healthy transitional cell epithelium, transitional cell carcinoma (TCC) in situ, and TCC of the urinary bladder. Forty-five TCCs (grades 1–3, 15 of each), 14 cases of TCC in situ, and 11 healthy bladder mucosal specimens were selected from archival collections of formalin-fixed bladder tissues. Slides were reacted with an anti-survivin antibody using a conventional immunohistochemical method and then were scored for nuclear and cytoplasmic staining. Statistical analysis of survivin expression was performed to evaluate the correlation of staining pattern with histologic diagnosis and clinical outcome. Nuclear staining for survivin was detected in 26 of 45 TCCs and in 2 of 14 cases of TCC in situ, but was not detected in healthy bladder mucosa. The association of nuclear staining with TCC versus both healthy bladder mucosa and TCC in situ was statistically significant (PKeywords
This publication has 15 references indexed in Scilit:
- MUTATION OF CELL CYCLE REGULATORS AND THEIR IMPACT ON SUPERFICIAL BLADDER CANCERUrologic Clinics of North America, 2000
- Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder CancerNew England Journal of Medicine, 1999
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- Control of apoptosis and mitotic spindle checkpoint by survivinNature, 1998
- Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene TargetingPublished by Elsevier ,1998
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997
- APOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell DeathAnnual Review of Medicine, 1997
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- DNA, RNA and Immunohistochemical Characterization of the HER-2/neu Oncogene in Transitional Cell Carcinoma of the BladderJournal of Urology, 1991